Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schulze

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Journal for Immunotherapy of Cancer|July 14, 2019
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker studyAndrea Forschner, Florian Battke, Dirk Hadaschik, et al.
Brain : a Journal of Neurology|April 23, 2019
Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmusAnja K Mayer, Muhammad Mahajnah, Mervyn G Thomas, et al.
Ear and Hearing|July 13, 2023
Variability in Cochlear Implantation Outcomes in a Large German Cohort With a Genetic Etiology of Hearing LossAnke Tropitzsch, Thore Schade-Mann, Philipp Gamerdinger, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
American Journal of Medical Genetics. Part A|November 25, 2022
Genetic and phenotypic spectrum in the NONO-associated syndromic disorderFranziska Roessler, Anita E Beck, Ball Susie, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
Breast (Edinburgh, Scotland)|January 24, 2025
Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiativeJan Henkel, Andreas Laner, Melanie Locher, et al.
Brain : a Journal of Neurology|April 19, 2016
SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre studyMatthis Synofzik, Katrien Smets, Martial Mallaret, et al.
Neuro-Oncology Advances|March 14, 2023
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous systemMirjam Renovanz, Sylvia C Kurz, Johannes Rieger, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Journal for Immunotherapy of Cancer|July 14, 2019
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker studyAndrea Forschner, Florian Battke, Dirk Hadaschik, et al.
Brain : a Journal of Neurology|April 23, 2019
Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmusAnja K Mayer, Muhammad Mahajnah, Mervyn G Thomas, et al.
Ear and Hearing|July 13, 2023
Variability in Cochlear Implantation Outcomes in a Large German Cohort With a Genetic Etiology of Hearing LossAnke Tropitzsch, Thore Schade-Mann, Philipp Gamerdinger, et al.
NPJ Precision Oncology|September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinomaMichael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
American Journal of Medical Genetics. Part A|November 25, 2022
Genetic and phenotypic spectrum in the NONO-associated syndromic disorderFranziska Roessler, Anita E Beck, Ball Susie, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
Breast (Edinburgh, Scotland)|January 24, 2025
Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiativeJan Henkel, Andreas Laner, Melanie Locher, et al.
Brain : a Journal of Neurology|April 19, 2016
SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre studyMatthis Synofzik, Katrien Smets, Martial Mallaret, et al.
Neuro-Oncology Advances|March 14, 2023
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous systemMirjam Renovanz, Sylvia C Kurz, Johannes Rieger, et al.
Pageof 17